Repligen Corp. Live Share Price Today, Share Analysis and Chart
108.3K XNAS Volume
XNAS 21 Mar, 2025 11:50 AM (EDT)
Repligen Corp. Key Metrics
Select
All financials are in USD Million and price data in USD
VIEW MORE
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Check Before You Buy
VIEW FULL CHECKLISTMedium rank
7Positive12Negative
36.8% Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
Repligen Corp. Stock Price Analysis
Day Price Range | 136.5 (LTP) 135.7139 LowHigh |
Week Price Range | 136.5 (LTP) 135.7153.9 LowHigh |
Month Price Range | 136.5 (LTP) 135.7168.1 LowHigh |
52 Week Price Range | 136.5 (LTP) 113.5200.2 LowHigh |
Repligen Corp. Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Hit
Repligen Corp.'s Revenue was higher than average estimate 3 times in past 3 years
EPS forecast
Current EPS
Avg. Estimate
Hit
EPS is expected to grow by 310.9% in FY25
Consensus Recommendation
19 ANALYST Recommendations
BUY
The consensus recommendation from 19 analysts for Repligen Corp. is BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get Repligen Corp. Stock Analysis
Repligen Corp. stock analysis with key metrics, changes, and trends.
Repligen Corp. Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Revenue | $634.44 M | 0.33% | positive |
| |
Annual Net Profit | $25.51 M | 171.68% | negative |
| |
Price to Earning Ratio | -300.35 | - | negative |
| |
Stock Price | $136.48 | -30.62% | negative |
| |
Quarterly Revenue | $167.55 M | 0.56% | positive |
| |
Quarterly Net profit | $33.87 M | 105.89% | negative |
| |
Mutual Fund Holding | 90.61 % | -0.22% | negative |
| |
Promoter Share Holding | 0.83 % | 0.02% | positive |
| |
Institutional Holding | 102.07 % | 0% | neutral |
|
Loading data..
Repligen Corp. - Company Profile
What does Repligen Corp. do?

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Repligen Corp. Management structure
All Gross Remunerations are in USD
Repligen Corp. Board of directors
All Gross Remunerations are in USD